Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

Show other versions (1)

<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer remains the deadliest of all cancers, with a mortality rate of 91%. Gemcitabine is considered the gold chemotherapeutic standard, but only marginally improves life-span due to its chemical instability and low cell p...

Full description

Bibliographic Details
Main Authors: Papa Anne-Laure, Basu Sudipta, Sengupta Poulomi, Banerjee Deboshri, Sengupta Shiladitya, Harfouche Rania
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Cancer
Subjects:
Gemcitabine
Pancreatic cancer
Liposome
Poly(lactic-co-glycolic acid)
Transmission electron microscopy
Online Access:http://www.biomedcentral.com/1471-2407/12/419

Internet

http://www.biomedcentral.com/1471-2407/12/419

Similar Items